Header Logo

Connection

FRITZ SEDLAZECK to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications FRITZ SEDLAZECK has written about Angiotensin-Converting Enzyme Inhibitors.
FRITZ SEDLAZECK
Connection Strength
0.042
Angiotensin-Converting Enzyme Inhibitors
  1. Shotgun transcriptome, spatial omics, and isothermal profiling of SARS-CoV-2 infection reveals unique host responses, viral diversification, and drug interactions. Nat Commun. 2021 03 12; 12(1):1660.
    View in: PubMed
    Score: 0.042
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.